Cancer cells often produce abnormal proteins that are processed and presented as tumor antigens via MHC molecules. Cytotoxic T cells recognize these antigens presented by MHC Class I molecules and can specifically target and kill cancer cells. Similarly, helper T cells recognize antigens presented by MHC Class II molecules, resulting in the activation of other immune cells.
